Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,794 | 2,603 | 1,373 | 12,030 | 9,518 |
| Depreciation Amortization | 533 | 350 | 175 | 700 | 531 |
| Accounts receivable | 267 | 73 | 2 | N/A | -1,022 |
| Other Working Capital | -9,673 | -6,368 | -2,596 | -16,670 | -11,332 |
| Other Operating Activity | 296 | 275 | 204 | 620 | 1,669 |
| Operating Cash Flow | $3,217 | $-3,067 | $-842 | $-3,320 | $-636 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,531 | 1,622 | 142 | N/A | -9,513 |
| PPE Investments | -753 | -497 | -480 | -140 | -105 |
| Other Investing Activity | 0 | 0 | 0 | -11,330 | 0 |
| Investing Cash Flow | $-4,284 | $1,125 | $-338 | $-11,470 | $-9,618 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,701 |
| Common Stock Issued | 10 | 4 | 5 | N/A | 14 |
| Other Financing Activity | -1,305 | -730 | -398 | -4,390 | -2,713 |
| Financing Cash Flow | $-1,295 | $-726 | $-393 | $-4,390 | $-4,400 |
| Exchange Rate Effect | -1,857 | -195 | -1,430 | -3,020 | -1,897 |
| Beginning Cash Position | 37,950 | 37,950 | 37,950 | 60,160 | 60,162 |
| End Cash Position | 33,731 | 35,087 | 34,947 | 37,950 | 43,611 |
| Net Cash Flow | $-4,219 | $-2,863 | $-3,003 | $-22,210 | $-16,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,217 | -3,067 | -842 | -3,320 | -636 |
| Capital Expenditure | -753 | -497 | -480 | N/A | -115 |
| Free Cash Flow | 2,464 | -3,564 | -1,322 | -3,320 | -751 |